Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/ANGN-BIOM-118621698/news/Elicio-Therapeutics-to-Present-Phase-1-Data-on-Cancer-Vaccine-Candidate-ELI-002-in-Patients-with-H-44772187/?utm_source=whatsapp&utm_medium=social&utm_campaign=share